Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Pancreatic Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05247905
What this trial is testing

Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors, the ComPareNET Trial

Who this might be right for
Metastatic Pancreatic Neuroendocrine TumorUnresectable Pancreatic Neuroendocrine Carcinoma
Alliance for Clinical Trials in Oncology 31
Early research (Phase 1)Study completedNCT01663272
What this trial is testing

A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Michigan Rogel Cancer Center 12
Early research (Phase 1)UnknownNCT02423239
What this trial is testing

Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours

Who this might be right for
Hepatocellular CarcinomaPancreatic Cancer
e-Therapeutics PLC 112
Early research (Phase 1)Study completedNCT01486329
What this trial is testing

VXM01 Phase I Dose Escalation Study in Patients With Locally Advanced, Inoperable and Stage IV Pancreatic Cancer

Who this might be right for
Stage IV Pancreatic Cancer
Vaximm GmbH 72
Testing effectiveness (Phase 2)Study completedNCT04902872
What this trial is testing

Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

Who this might be right for
Solid Tumor, AdultEpithelial Ovarian CancerSmall Cell Lung Carcinoma+9 more
Cybrexa Therapeutics 69
Testing effectiveness (Phase 2)UnknownNCT01182246
What this trial is testing

AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer

Who this might be right for
Adenocarcinoma
Axcentua Pharmaceuticals AB 44
Early research (Phase 1)WithdrawnNCT06487377
What this trial is testing

IX001 TCR-T In the Treatment of Advanced Pancreatic Cancer and Colorectal Cancer Induced by KRAS Mutations

Who this might be right for
Pancreatic CancerColorectal Cancer
Shanghai Pudong Hospital
Early research (Phase 1)Active Not RecruitingNCT05083780
What this trial is testing

Hydroxychloroquine and Chlorphenesin Carbamate in Combination With mFOLFIRINOX in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Changhoon Yoo 40
Early research (Phase 1)UnknownNCT05315180
What this trial is testing

A Phase 1，Open-label Study of BPI-421286 in Subjects With Advanced Solid Tumors

Who this might be right for
Malignant NeoplasmsMetastatic Cancer
Betta Pharmaceuticals Co., Ltd. 80
Early research (Phase 1)Study completedNCT00551096
What this trial is testing

Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors

Who this might be right for
Malignant Solid TumourBiliary CancerPancreatic Cancer
University of Colorado, Denver 23
Testing effectiveness (Phase 2)Study completedNCT00026403
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Alliance for Clinical Trials in Oncology 48
Very early researchWithdrawnNCT05238831
What this trial is testing

SMMART Adaptive Clinical Treatment (ACT) Trial

Who this might be right for
Advanced Breast CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian Carcinoma+14 more
OHSU Knight Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT00948688
What this trial is testing

Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic CancerAdenocarcinoma of the Pancreas
Massachusetts General Hospital 10
Early research (Phase 1)Study completedNCT03784677
What this trial is testing

A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmRefractory Malignant Solid NeoplasmRefractory Ovarian Carcinoma+20 more
M.D. Anderson Cancer Center 11
Not applicableEnded earlyNCT00660348
What this trial is testing

Standard Pain Control or Intrathecal Therapy in Controlling Pain in Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer

Who this might be right for
PainPancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1
Testing effectiveness (Phase 2)Looking for participantsNCT05988814
What this trial is testing

Trial Evaluating the Efficacy and the Safety of FOLFIRINOX3 Treatment in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer in First Line of Chemotherapy

Who this might be right for
Metastatic Pancreatic Cancer
Centre Georges Francois Leclerc 90
Large-scale testing (Phase 3)Study completedNCT00058149
What this trial is testing

Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Eastern Cooperative Oncology Group
Early research (Phase 1)Study completedNCT00003426
What this trial is testing

Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00019474
What this trial is testing

Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGastric CancerGastrointestinal Carcinoid Tumor+3 more
Montefiore Medical Center 60
Early research (Phase 1)UnknownNCT03098160
What this trial is testing

Immunotherapy Study of Evofosfamide in Combination With Ipilimumab

Who this might be right for
Pancreatic CancerMelanomaSquamous Cell Carcinoma of the Head and Neck+1 more
Threshold Pharmaceuticals 69
Next Page